JF
CBIO

Jump Financial’s Crescent Biopharma CBIO Stock Holding History

Jump Financial’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-115
Closed -$1.95K – 1791
2024
Q3 		$1.95K Buy
+115
New +$2.41K ﹤0.01% 1578
2024
Q2 		– Sell
-201
Closed -$60.3K – 1970
2024
Q1 		$60.3K Buy
+201
New +$60K ﹤0.01% 1824
2021
Q3 		– Sell
-180
Closed -$42K – 1236
2021
Q2 		$42K Buy
+180
New +$45.8K ﹤0.01% 1035
2021
Q1 		– Sell
-262
Closed -$99K – 1066
2020
Q4 		$99K Buy
+262
New +$91.8K 0.02% 869

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return